George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 8,092 shares at $43.97 ($356K) on 2022-07-28, disclosed to the SEC on 2022-08-01.
Open-market sale of $356k RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.97 | 4,046 | $178K | 50.0% |
| 2 | $43.97 | 4,046 | $178K | 50.0% |
| Total | $43.97 avg | 8,092 | $356K | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |